Discover trends, market shifts, and competitive outlooks for the neurological biomarkers industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What is the Projected CAGR for the Neurological Biomarkers Market Size from 2025 to 2034?

In recent years, the expansion of the neurological biomarkers market has been swift. The market which was worth $10.7 billion in 2024 is projected to increase to $11.96 billion in 2025, with a compound annual growth rate (CAGR) of 11.7%. This significant growth during the historical period is due to several factors, including the rising incidence of neurological disorders, an aging population, the necessity for drug development, heightened funding for neurological research, and the shift towards personalized medicine.

Over the coming years, the market size for neurological biomarkers is projected to expand quickly. The market is estimated to reach a value of $19.96 billion in 2029, demonstrating a compound annual growth rate (CAGR) of 13.7%. This growth during the estimate period is due to factors including early detection biomarkers, biosensors, wearable devices, global health initiatives, and a patient-centric approach. The forecast period will also see major trends such as technological innovations in imaging, swift progress in omics technologies, the incorporation of artificial intelligence (AI), real-world verification of biomarkers, advances in diagnostic technologies, and collaboration between industrial sectors and research institutions.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12677&type=smp

Which Primay Drivers Are Accelerating Growth in the Neurological Biomarkers Market?

The surge in neurological disorders is predicted to trigger the expansion of the neurological biomarker market. Neurological conditions impact the brain, spinal cord, and all other nervous systems of the body. Parkinson’s disease, a neurodegenerative disease, affects the neurological system and body parts that are managed by the nerves. Neurological biomarkers aid in early diagnosis of Parkinson’s disease through pathological, biochemical, and genetic testing. For example, the Parkinson’s Foundation – a non-profit based in the US, reported in December 2022 that the instances of new Parkinson’s disease diagnoses reached 90,000 in 2022, a rise from 60,000 in 2021. Hence, the escalating prevalence of neurological diseases is bolstering the growth of the neurological biomarker market.

Which Primary Segments of the Neurological Biomarkers Market Are Driving Growth and Industry Transformations?

The neurological biomarkers market covered in this report is segmented –

1) By Product: Proteomics Biomarker, Genomics Biomarker, Metabolomics Biomarker, Imaging Biomarker, Other Products

2) By Application: Alzheimer’s Disease, Parkinson’s Disease, Huntington’s Disease, Schizophrenia, Depression, Multiple Sclerosis, Spinal Muscular Atrophy

3) By End-User: Hospital Laboratories, Clinical Diagnostic Centers, Research Organizations, Other End-Users

Subsegments:

1) By Proteomics Biomarker: Protein Biomarkers, Antibody Biomarkers

2) By Genomics Biomarker: DNA Biomarkers, RNA Biomarkers

3) By Metabolomics Biomarker: Metabolite Biomarkers, Lipid Biomarkers

4) By Imaging Biomarker: MRI Biomarkers, PET Scan Biomarkers

5) By Other Products: Neuroinflammatory Biomarkers, Neurotransmitter Biomarkers

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=12677&type=smp

Which Regions Are Key Players in the Growth of the #Which Primay Drivers Are Accelerating Growth in the Neurological Biomarkers Market?# Market?

North America was the largest region in the neurological biomarkers market in 2024. The regions covered in the neurological biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Which Technological Trends Are Reshaping the Neurological Biomarkers Industry Dynamics?

Key firms in the neurological biomarkers industry are forming partnerships to produce new products and reinforce their market dominance. Collaboration and partnerships spur innovation, utilize complementary skill sets, and facilitate faster development and commercialization of pioneering therapies by pooling resources and strengths. For instance, in July 2022, NeuroSense Therapeutics Ltd., an Israeli company engaged in devising treatments for extreme neurodegenerative diseases, allied itself with NeuraLight, another Israeli firm focused on developing precise and sensitive biomarkers for neurological ailments. This partnership aims at identifying oculometric indicators for Amyotrophic Lateral Sclerosis (ALS) through the use of Artificial Intelligence (AI) and Machine Learning (ML). Following NeuraLight’s $25 million Series A funding, the alliance aspires to heighten the identification and usage of ALS digital indications in a concurrent investigation. This marks the beginning of the collaboration’s first clinical trial and primarily concentrates on utilizing oculometric digital indicators, which could facilitate patient segmentation and increase the chances of success in clinical trials.

View the full report here:

https://www.thebusinessresearchcompany.com/report/neurological-biomarkers-global-market-report

What Parameters Are Used to Define the Neurological Biomarkers Market?

A neurological biomarker is a substance that provides objective and quantifiable information about the presence, progression, or characteristics of a neurological disorder or condition. They are used in clinical practice during drug development.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12677

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model